StockData
Aethlon Medical Inc logo

Aethlon Medical Inc (AEMD) stock

AEMDNasdaqPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$5.11+0.03 (+0.59%)

Close on Nov 18, 2026Market cap $3.63MP/E –Yield –

Aethlon Medical free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Aethlon Medical's free cash flow for the twelve months ending Mar 31, 2026 was -$7.00M. For fiscal 2026 it was -$7.00M. The highest annual figure on record is -$1.84M in fiscal 2012.

Annual free cash flow

PeriodPeriod endValueChange
FY2026Mar 31, 2026-$7.00M–
FY2025Mar 31, 2025-$7.65M–
FY2024Mar 31, 2024-$10.38M–
FY2023Mar 31, 2023-$11.45M–
FY2022Mar 31, 2022-$10.12M–
FY2021Mar 31, 2021-$6.82M–
FY2020Mar 31, 2020-$5.35M–
FY2019Mar 31, 2019-$4.29M–
FY2018Mar 31, 2018-$3.94M–
FY2017Mar 31, 2017-$3.52M–
FY2016Mar 31, 2016-$4.34M–
FY2015Mar 31, 2015-$5.05M–
FY2014Mar 31, 2014-$2.24M–
FY2013Mar 31, 2013-$2.10M–
FY2012Mar 31, 2012-$1.84M–
FY2011Mar 31, 2011-$1.97M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jun 30, 2026-$1.91M–
Q4 FY2026CQ1 2026Mar 31, 2026-$1.75M–
Q1 FY2026CQ2 2025Jun 30, 2025-$1.71M–
Q4 FY2025CQ1 2025Mar 31, 2025-$1.67M–
Q3 FY2025CQ4 2024Dec 31, 2024-$2.01M–
Q2 FY2025CQ3 2024Sep 30, 2024-$2.21M–
Q1 FY2025CQ2 2024Jun 30, 2024-$1.75M–
Q4 FY2024CQ1 2024Mar 31, 2024-$2.57M–
Q3 FY2024CQ4 2023Dec 31, 2023-$2.39M–
Q2 FY2024CQ3 2023Sep 30, 2023-$2.71M–
Q1 FY2024CQ2 2023Jun 30, 2023-$2.71M–
Q4 FY2023CQ1 2023Mar 31, 2023-$2.96M–
Q3 FY2023CQ4 2022Dec 31, 2022-$2.10M–
Q2 FY2023CQ3 2022Sep 30, 2022-$3.62M–
Q1 FY2023CQ2 2022Jun 30, 2022-$2.77M–
Q4 FY2022CQ1 2022Mar 31, 2022-$3.31M–
Q3 FY2022CQ4 2021Dec 31, 2021-$2.78M–
Q2 FY2022CQ3 2021Sep 30, 2021-$1.92M–
Q1 FY2022CQ2 2021Jun 30, 2021-$2.11M–
Q4 FY2021CQ1 2021Mar 31, 2021-$2.24M–
Q3 FY2021CQ4 2020Dec 31, 2020-$2.23M–
Q2 FY2021CQ3 2020Sep 30, 2020-$1.23M–
Q1 FY2021CQ2 2020Jun 30, 2020-$1.12M–
Q4 FY2020CQ1 2020Mar 31, 2020-$1.62M–
Q3 FY2020CQ4 2019Dec 31, 2019-$1.28M–
Q2 FY2020CQ3 2019Sep 30, 2019-$1.19M–
Q1 FY2020CQ2 2019Jun 30, 2019-$1.25M–
Q4 FY2019CQ1 2019Mar 31, 2019-$1.40M–
Q3 FY2019CQ4 2018Dec 31, 2018-$1.09M–
Q2 FY2019CQ3 2018Sep 30, 2018-$991.27K–
Q1 FY2019CQ2 2018Jun 30, 2018-$818.43K–
Q4 FY2018CQ1 2018Mar 31, 2018-$1.02M–
Q3 FY2018CQ4 2017Dec 31, 2017-$789.67K–
Q2 FY2018CQ3 2017Sep 30, 2017-$1.03M–
Q1 FY2018CQ2 2017Jun 30, 2017-$1.10M–
Q4 FY2017CQ1 2017Mar 31, 2017-$967.44K–
Q3 FY2017CQ4 2016Dec 31, 2016-$788.24K–
Q2 FY2017CQ3 2016Sep 30, 2016-$937.18K–
Q1 FY2017CQ2 2016Jun 30, 2016-$829.48K–

More Aethlon Medical figures

See a number that looks wrong?